How Does FemiLift Vaginal Rejuvenation Work?

Are you looking for a non-surgical treatment to tackle your feminine health issues? FemiLift by Alma Lasers may be just what you need. FemiLift is an effective non-invasive procedure that can treat a variety of feminine health concerns with minimal downtime. But what exactly is FemiLift vaginal rejuvenation and how does it work.

What is FemiLift?

FemiLift is a minimally invasive vaginal rejuvenation treatment that tones and tightens the vaginal tissues. Aging, childbirth, and hormone changes can cause the muscles in the vagina to stretch and loosen. This can lead to symptoms such as vaginal laxity, vaginal dryness, and stress urinary incontinence, which can cause discomfort, and affect a woman’s confidence. FemiLift is specially designed to address these concerns.

FemiLift is a safe, pain-free treatment that takes approximately 30 minutes to complete, and delivers immediate results. However, a series of 3 treatments is recommended for optimal results.

How does FemiLift vaginal rejuvenation work?

The laser emits fractional CO2 energy that heats the vaginal tissues and causes the collagen fibers within it to contract. It also stimulates the formation of new collagen. The additional collagen enhances the strength and flexibility of the vaginal tissues. FemiLift also increases lubrication and improves blood flow (learn more).

What to expect after treatment

There is no downtime after FemiLift so patients can resume normal activities. However, sexual intercourse should be avoided for at least 3 days.

Am I a good candidate for FemiLift?

If you are experiencing symptoms such as vaginal dryness, painful intercourse, or stress urinary incontinence, you may be a good candidate for FemiLift.

Are you interested in FemiLift vaginal rejuvenation? Search our directory to find a practice in your area.

If you are in the Philadelphia, PA area, The Pennsylvania Center for Plastic Surgery is our featured practice.

You can reach them at, or by calling (267)-687-2180.

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest